|
Patrick McManamny
Senior Associate
28 Sep 2011
FB Rice partner Dr. Jenny Petering, and colleagues Dr. Patrick McManamny and Ms Jane Honeyman have published an article entitled: 'Antibody Therapeutics – The Evolving Patent Landscape' in the highly regarded journal, New Biotechnology.
02 Feb 2011
Historically, an Australian divisional application could be filed to extend prosecution of claims that were not accepted in the parent application. The Australian Patent Office (“the Office") has implemented a new practice designed to limit the use of divisional applications to extend the period for having claims examined and accepted.
27 Jul 2010
In the first of our Education Series, Senior Associate Patrick McManamny explores some of the practical considerations for Patent Freedom to Operate Searches.
06 Apr 2010
A discussion on the Patient Protection and Affordable Care Act, (HB 3590), which was recently signed into law, and its affects on manufacturers and innovators of biological products.
|
Patrick has experience in preparing and prosecuting patent applications in major industrial jurisdictions, providing patentability advice and advising on freedom-to-operate and patent landscapes. Patrick joined FB Rice in 2002 as a trainee attorney and, in 2006 registered as a patent attorney in Australia and New Zealand and as a trade marks attorney in Australia. Following a brief period acting as in-house patent counsel, Patrick returned to FB Rice as an Associate in 2008, and became a Senior Associate in 2011.
Patrick’s PhD focused on production and study of cell and transgenic models of human neurodegenerative disease. During his PhD studies, Patrick was also awarded a postgraduate fellowship to provide technical assistance in projects involving a diverse range of technologies, such as yeast two-hybrid screens, production of transgenic and knockout mice and stem cell biology.
|
|
-
BSc from La Trobe University majoring in genetics and zoology.
-
Honours and PhD at Monash Institute of Reproduction and Development (now Monash Institute of Medical Research).
-
Graduate Diploma in Intellectual Property Law from the University of Melbourne
-
Antibody technology
-
Protein/peptide biochemistry and peptide-based therapeutics
-
Molecular and protein-based diagnostics
-
Cell biology, including stem cell biology
-
Gene cloning and expression
-
Transgenic organisms
-
Biomarker identification
-
Drug-screening techniques
|
